These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
561 related articles for article (PubMed ID: 16085325)
21. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks]. Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206 [TBL] [Abstract][Full Text] [Related]
22. Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks. Onat A; Can G; Ayhan E; Kaya Z; Hergenç G Metabolism; 2009 Oct; 58(10):1393-9. PubMed ID: 19570555 [TBL] [Abstract][Full Text] [Related]
23. Cross-sectional study of complement C3 as a coronary risk factor among men and women. Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975 [TBL] [Abstract][Full Text] [Related]
24. Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation. Onat A; Can G; Hergenç G; Yazici M; Karabulut A; Albayrak S Int J Obes (Lond); 2007 Jul; 31(7):1119-25. PubMed ID: 17299378 [TBL] [Abstract][Full Text] [Related]
25. A high risk score for coronary heart disease is associated with the metabolic syndrome in 40-year-old men and women. Tonstad S; Hjermann I J Cardiovasc Risk; 2003 Apr; 10(2):129-35. PubMed ID: 12668910 [TBL] [Abstract][Full Text] [Related]
26. Lipids, lipoproteins and apolipoproteins among turks, and impact on coronary heart disease. Onat A Anadolu Kardiyol Derg; 2004 Sep; 4(3):236-45. PubMed ID: 15355827 [TBL] [Abstract][Full Text] [Related]
27. Cardiorespiratory fitness and body mass index as predictors of cardiovascular disease mortality among men with diabetes. Church TS; LaMonte MJ; Barlow CE; Blair SN Arch Intern Med; 2005 Oct; 165(18):2114-20. PubMed ID: 16217001 [TBL] [Abstract][Full Text] [Related]
28. A consultation-based method is equal to SCORE and an extensive laboratory-based method in predicting risk of future cardiovascular disease. Petersson U; Ostgren CJ; Brudin L; Nilsson PM Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):536-40. PubMed ID: 19357517 [TBL] [Abstract][Full Text] [Related]
30. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589 [TBL] [Abstract][Full Text] [Related]
31. Cardiovascular risk factor prevalence among men in a large industry of northern India. Prabhakaran D; Shah P; Chaturvedi V; Ramakrishnan L; Manhapra A; Reddy KS Natl Med J India; 2005; 18(2):59-65. PubMed ID: 15981439 [TBL] [Abstract][Full Text] [Related]
32. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW Circulation; 2004 Jul; 110(4):380-5. PubMed ID: 15262834 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia. Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305 [TBL] [Abstract][Full Text] [Related]
34. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study. Noda H; Iso H; Saito I; Konishi M; Inoue M; Tsugane S; Hypertens Res; 2009 Apr; 32(4):289-98. PubMed ID: 19262490 [TBL] [Abstract][Full Text] [Related]
35. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067 [TBL] [Abstract][Full Text] [Related]
36. Trends in prevalence of coronary risk factors in an urban Indian population: Jaipur Heart Watch-4. Gupta R; Kaul V; Bhagat N; Agrawal M; Gupta VP; Misra A; Vikram NK Indian Heart J; 2007; 59(4):346-53. PubMed ID: 19126941 [TBL] [Abstract][Full Text] [Related]
37. High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides. Borggreve SE; Hillege HL; Dallinga-Thie GM; de Jong PE; Wolffenbuttel BH; Grobbee DE; van Tol A; Dullaart RP; Eur Heart J; 2007 Apr; 28(8):1012-8. PubMed ID: 17409111 [TBL] [Abstract][Full Text] [Related]
38. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study. Fiuza M; Cortez-Dias N; Martins S; Belo A; Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993 [TBL] [Abstract][Full Text] [Related]
39. Sex-specific cardiovascular morbidity and mortality in a cohort treated for hypertension. Li C; Engström G; Hedblad B; Janzon L J Hypertens; 2006 Aug; 24(8):1523-9. PubMed ID: 16877954 [TBL] [Abstract][Full Text] [Related]
40. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study. Strasak AM; Kelleher CC; Brant LJ; Rapp K; Ruttmann E; Concin H; Diem G; Pfeiffer KP; Ulmer H; Int J Cardiol; 2008 Apr; 125(2):232-9. PubMed ID: 18237790 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]